New Genetic Discovery Helps Improve Warfarin Drug Dosing Dilemma
Marshfield Clinic research team uses the Affymetrix DMET solution to discover a genetic variant that explains approximately eight percent of a patient's variable response to warfarin
Read press release Learn more